MYOM3
gene geneOn this page
Also known as FLJ35961
Summary
MYOM3 (myomesin 3, HGNC:26679) is a protein-coding gene on chromosome 1p36.11, encoding Myomesin-3 (Q5VTT5). May link the intermediate filament cytoskeleton to the M-disk of the myofibrils in striated muscle.
Predicted to enable protein homodimerization activity. Predicted to be involved in sarcomere organization. Predicted to be located in cytoplasm. Predicted to be active in M band.
Source: NCBI Gene 127294 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 306 total
- MANE Select transcript:
NM_152372
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26679 |
| Approved symbol | MYOM3 |
| Name | myomesin 3 |
| Location | 1p36.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ35961 |
| Ensembl gene | ENSG00000142661 |
| Ensembl biotype | protein_coding |
| OMIM | 616832 |
| Entrez | 127294 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 7 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000338909, ENST00000374434, ENST00000448831, ENST00000475306, ENST00000958996, ENST00000958997, ENST00000958998, ENST00000958999, ENST00000959000
RefSeq mRNA: 1 — MANE Select: NM_152372
NM_152372
CCDS: CCDS41281
Canonical transcript exons
ENST00000374434 — 37 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001036491 | 24076159 | 24076273 |
| ENSE00001036528 | 24081330 | 24081456 |
| ENSE00001036557 | 24080016 | 24080194 |
| ENSE00001036603 | 24068223 | 24068367 |
| ENSE00001036624 | 24075319 | 24075475 |
| ENSE00001130197 | 24067970 | 24068029 |
| ENSE00001209336 | 24074160 | 24074269 |
| ENSE00001209369 | 24084468 | 24084639 |
| ENSE00001269847 | 24071969 | 24072013 |
| ENSE00001269884 | 24082593 | 24082714 |
| ENSE00001298529 | 24067021 | 24067088 |
| ENSE00001305943 | 24071117 | 24071253 |
| ENSE00001308604 | 24061946 | 24062109 |
| ENSE00001311444 | 24064072 | 24064159 |
| ENSE00001313938 | 24058924 | 24058979 |
| ENSE00001322463 | 24063492 | 24063530 |
| ENSE00001325915 | 24063126 | 24063234 |
| ENSE00001391725 | 24082001 | 24082188 |
| ENSE00001406157 | 24112031 | 24112135 |
| ENSE00001463517 | 24061060 | 24061082 |
| ENSE00001463521 | 24061273 | 24061309 |
| ENSE00001463523 | 24065891 | 24066001 |
| ENSE00001710631 | 24107993 | 24108073 |
| ENSE00001884685 | 24056041 | 24057627 |
| ENSE00002319606 | 24108476 | 24108654 |
| ENSE00003491044 | 24092947 | 24093108 |
| ENSE00003505955 | 24086644 | 24086827 |
| ENSE00003510052 | 24107073 | 24107232 |
| ENSE00003512664 | 24097923 | 24098011 |
| ENSE00003518590 | 24089538 | 24089665 |
| ENSE00003518846 | 24092174 | 24092315 |
| ENSE00003535050 | 24095442 | 24095486 |
| ENSE00003591711 | 24090065 | 24090118 |
| ENSE00003605246 | 24094853 | 24094990 |
| ENSE00003622252 | 24105920 | 24106077 |
| ENSE00003630087 | 24090797 | 24090996 |
| ENSE00003641470 | 24099680 | 24099775 |
Expression profiles
Bgee: expression breadth ubiquitous, 175 present calls, max score 98.49.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 2.1111 / max 336.9549, expressed in 111 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 11033 | 1.8654 | 78 |
| 11034 | 0.1269 | 30 |
| 11032 | 0.0661 | 27 |
| 201409 | 0.0416 | 23 |
| 11031 | 0.0110 | 7 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 98.49 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 98.29 | gold quality |
| gastrocnemius | UBERON:0001388 | 97.56 | gold quality |
| heart left ventricle | UBERON:0002084 | 97.43 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 97.30 | gold quality |
| cardiac ventricle | UBERON:0002082 | 97.20 | gold quality |
| right atrium auricular region | UBERON:0006631 | 97.16 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 97.12 | gold quality |
| cardiac atrium | UBERON:0002081 | 96.91 | gold quality |
| tibialis anterior | UBERON:0001385 | 96.65 | gold quality |
| muscle of leg | UBERON:0001383 | 96.13 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 95.61 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 94.12 | gold quality |
| heart right ventricle | UBERON:0002080 | 93.47 | gold quality |
| vastus lateralis | UBERON:0001379 | 92.32 | gold quality |
| quadriceps femoris | UBERON:0001377 | 92.19 | gold quality |
| heart | UBERON:0000948 | 91.82 | gold quality |
| myocardium | UBERON:0002349 | 91.77 | gold quality |
| deltoid | UBERON:0001476 | 91.43 | silver quality |
| biceps brachii | UBERON:0001507 | 90.89 | gold quality |
| muscle tissue | UBERON:0002385 | 90.57 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 89.76 | gold quality |
| body of tongue | UBERON:0011876 | 87.27 | gold quality |
| pancreatic ductal cell | CL:0002079 | 86.01 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 83.85 | gold quality |
| buccal mucosa cell | CL:0002336 | 82.57 | gold quality |
| kidney epithelium | UBERON:0004819 | 81.40 | silver quality |
| kidney | UBERON:0002113 | 80.19 | gold quality |
| tongue | UBERON:0001723 | 79.51 | gold quality |
| upper arm skin | UBERON:0004263 | 77.78 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.67 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
44 targeting MYOM3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4713-3P | 100.00 | 65.92 | 505 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-7152-3P | 99.97 | 67.47 | 849 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-6753-3P | 99.93 | 66.57 | 637 |
| HSA-MIR-7107-3P | 99.93 | 66.73 | 627 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
| HSA-MIR-3689A-3P | 99.70 | 65.73 | 2306 |
| HSA-MIR-3689B-3P | 99.70 | 65.71 | 2311 |
| HSA-MIR-3689C | 99.70 | 65.71 | 2311 |
| HSA-MIR-6779-5P | 99.70 | 65.76 | 2363 |
| HSA-MIR-6132 | 99.60 | 65.83 | 1554 |
| HSA-MIR-6836-5P | 99.60 | 65.62 | 1538 |
| HSA-MIR-671-5P | 99.52 | 67.11 | 1277 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-4735-5P | 99.43 | 68.49 | 1780 |
| HSA-MIR-532-3P | 99.34 | 65.76 | 1195 |
| HSA-MIR-4254 | 99.11 | 65.15 | 1315 |
| HSA-MIR-328-5P | 99.08 | 64.65 | 1000 |
| HSA-MIR-6885-5P | 98.71 | 64.33 | 902 |
| HSA-MIR-4725-5P | 98.67 | 65.42 | 628 |
Literature-anchored findings (GeneRIF, showing 3)
- MYOM3 fragments hold promise for minimally invasive assessment of experimental therapies for DMD and other neuromuscular disorders. (PMID:26060189)
- mutations in Pakistani patients with dilated cardiomyopathy rs375563861 (C2orf40), rs143187236 (MYOM3), and rs564181443 (RTKN2) have 3 fold or higher allele frequency in South Asians than in the global populations (PMID:29886034)
- An acute eccentric exercise increases circulating myomesin 3 fragments. (PMID:33468054)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Myom3 | ENSMUSG00000037139 |
| rattus_norvegicus | Myom3 | ENSRNOG00000032994 |
| drosophila_melanogaster | mtgo | FBGN0259735 |
| caenorhabditis_elegans | WBGENE00007944 |
Paralogs (11): MYOM2 (ENSG00000036448), FNDC3B (ENSG00000075420), MYBPC2 (ENSG00000086967), MYOM1 (ENSG00000101605), FNDC3A (ENSG00000102531), OBSL1 (ENSG00000124006), MYBPH (ENSG00000133055), MYBPC3 (ENSG00000134571), IGSF22 (ENSG00000179057), MYBPC1 (ENSG00000196091), MYBPHL (ENSG00000221986)
Protein
Protein identifiers
Myomesin-3 — Q5VTT5 (reviewed: Q5VTT5)
Alternative names: Myomesin family member 3
All UniProt accessions (1): Q5VTT5
UniProt curated annotations — full annotation on UniProt →
Function. May link the intermediate filament cytoskeleton to the M-disk of the myofibrils in striated muscle.
Subunit / interactions. Homodimer.
Subcellular location. Cytoplasm. Myofibril. Sarcomere. M line.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5VTT5-1 | 1 | yes |
| Q5VTT5-2 | 2 | |
| Q5VTT5-3 | 3 |
RefSeq proteins (1): NP_689585* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003598 | Ig_sub2 | Domain |
| IPR003599 | Ig_sub | Domain |
| IPR003961 | FN3_dom | Domain |
| IPR007110 | Ig-like_dom | Domain |
| IPR013098 | Ig_I-set | Domain |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036116 | FN3_sf | Homologous_superfamily |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
| IPR050964 | Striated_Muscle_Regulatory | Family |
Pfam: PF00041, PF07679
UniProt features (34 total): sequence variant 12, domain 9, sequence conflict 5, splice variant 4, chain 1, region of interest 1, coiled-coil region 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VTT5-F1 | 76.55 | 0.19 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 69 (showing top):
GCANCTGNY_MYOD_Q6, GOBP_STRIATED_MUSCLE_CELL_DIFFERENTIATION, TGACCTY_ERR1_Q2, GOBP_SARCOMERE_ORGANIZATION, GOBP_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS, GOBP_MUSCLE_STRUCTURE_DEVELOPMENT, GOBP_ACTOMYOSIN_STRUCTURE_ORGANIZATION, GRE_C, GOBP_ORGANELLE_ASSEMBLY, GOMF_STRUCTURAL_CONSTITUENT_OF_MUSCLE, E12_Q6, GOBP_MUSCLE_CELL_DEVELOPMENT, TGACCTTG_SF1_Q6, GOBP_MUSCLE_CELL_DIFFERENTIATION, GOCC_M_BAND
GO Biological Process (1): sarcomere organization (GO:0045214)
GO Molecular Function (3): protein homodimerization activity (GO:0042803), protein binding (GO:0005515), identical protein binding (GO:0042802)
GO Cellular Component (2): M band (GO:0031430), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| myofibril assembly | 1 |
| actomyosin structure organization | 1 |
| identical protein binding | 1 |
| protein dimerization activity | 1 |
| binding | 1 |
| protein binding | 1 |
| A band | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
742 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MYOM3 | SGCA | Q16586 | 552 |
| MYOM3 | MYOZ2 | Q9NPC6 | 538 |
| MYOM3 | TNNI1 | P19237 | 515 |
| MYOM3 | COX6A2 | Q02221 | 472 |
| MYOM3 | MYOM2 | P54296 | 434 |
| MYOM3 | MYL1 | P05976 | 431 |
| MYOM3 | LRRC39 | Q96DD0 | 427 |
| MYOM3 | ANKRD2 | Q9GZV1 | 425 |
| MYOM3 | CSRP3 | P50461 | 425 |
| MYOM3 | TNNT3 | P45378 | 421 |
| MYOM3 | MYH7 | P12883 | 418 |
| MYOM3 | TNNI2 | P48788 | 413 |
| MYOM3 | MYL3 | P08590 | 410 |
| MYOM3 | TNNT1 | P13805 | 393 |
| MYOM3 | CKMT2 | P17540 | 389 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| MRPS23 | MYH7B | psi-mi:“MI:0914”(association) | 0.350 |
| CSNK2B | TUBAL3 | psi-mi:“MI:0914”(association) | 0.350 |
| AMOT | MYOM3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MYOM3 | ASH2L | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (10): MYOM3 (Affinity Capture-MS), MYOM3 (Affinity Capture-MS), MYOM3 (Two-hybrid), MYOM3 (Two-hybrid), MYOM3 (Two-hybrid), MYOM3 (Two-hybrid), MYOM3 (Two-hybrid), MYOM3 (Two-hybrid), MYOM3 (Affinity Capture-RNA), SPG21 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A087WV53, A1CS92, A2ABU4, A2Q908, A2RUH7, A4QZL9, D3ZHA0, O01761, O70468, O75369, O88599, P05548, P11275, P11730, P11798, P13466, P21333, P56276, P56741, P70402, P79280, Q05623, Q13177, Q13203, Q13557, Q14315, Q2GM53, Q2HJF7, Q2URB7, Q5FW53, Q5PQM4, Q5RCC4, Q5VTT5, Q5ZJJ9, Q5ZKI0, Q62422, Q63518, Q6C1H8, Q6P686, Q6PHZ2
Diamond homologs: A0JN74, A1L4K1, A2ABU4, A2ASS6, B1H278, H0UZ81, O00478, P18892, P82456, Q02084, Q13410, Q1XHU0, Q495X7, Q5BN31, Q5D7I0, Q5R7W8, Q5R996, Q5VTT5, Q6MFZ5, Q6UX41, Q6UXE8, Q70KF4, Q7YRV4, Q8BVW3, Q8BZ52, Q8N3K9, Q8VI40, Q8WVV5, Q8WZ42, Q91431, Q96F44, Q96KV6, Q96PL5, Q99PQ2, Q9ESN2, Q9HCM9, Q9JLN5, A2AAJ9, O88599, P12960
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
306 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 259 |
| Likely benign | 17 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4663 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:24057628:C:CC | acceptor_gain | 1.0000 |
| 1:24057632:T:TC | acceptor_gain | 1.0000 |
| 1:24058928:T:C | donor_gain | 1.0000 |
| 1:24061058:A:AC | donor_gain | 1.0000 |
| 1:24061059:C:CC | donor_gain | 1.0000 |
| 1:24061940:GCTCA:G | donor_loss | 1.0000 |
| 1:24061941:CTCAC:C | donor_loss | 1.0000 |
| 1:24061942:TCA:T | donor_loss | 1.0000 |
| 1:24061943:CACCT:C | donor_loss | 1.0000 |
| 1:24061944:A:AG | donor_loss | 1.0000 |
| 1:24061981:T:TA | donor_gain | 1.0000 |
| 1:24061986:C:A | donor_gain | 1.0000 |
| 1:24062105:TGTCT:T | acceptor_gain | 1.0000 |
| 1:24062106:GTCT:G | acceptor_gain | 1.0000 |
| 1:24062108:CT:C | acceptor_gain | 1.0000 |
| 1:24062109:TC:T | acceptor_loss | 1.0000 |
| 1:24062110:C:CC | acceptor_gain | 1.0000 |
| 1:24062110:C:CG | acceptor_loss | 1.0000 |
| 1:24062111:T:A | acceptor_loss | 1.0000 |
| 1:24062114:A:AC | acceptor_gain | 1.0000 |
| 1:24062114:A:C | acceptor_gain | 1.0000 |
| 1:24062116:G:C | acceptor_gain | 1.0000 |
| 1:24062116:G:GC | acceptor_gain | 1.0000 |
| 1:24063122:TTAC:T | donor_loss | 1.0000 |
| 1:24063123:TACTT:T | donor_loss | 1.0000 |
| 1:24063124:A:AC | donor_gain | 1.0000 |
| 1:24063124:A:T | donor_loss | 1.0000 |
| 1:24063125:C:CA | donor_gain | 1.0000 |
| 1:24063125:CT:C | donor_gain | 1.0000 |
| 1:24063125:CTT:C | donor_gain | 1.0000 |
AlphaMissense
9347 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:24057445:G:C | N1411K | 0.999 |
| 1:24057445:G:T | N1411K | 0.999 |
| 1:24076239:A:G | F874S | 0.999 |
| 1:24080089:A:T | V838D | 0.999 |
| 1:24080136:C:A | W822C | 0.999 |
| 1:24080136:C:G | W822C | 0.999 |
| 1:24080138:A:G | W822R | 0.999 |
| 1:24080138:A:T | W822R | 0.999 |
| 1:24081422:A:G | F772S | 0.999 |
| 1:24082123:A:G | W720R | 0.999 |
| 1:24082123:A:T | W720R | 0.999 |
| 1:24082673:A:G | F671S | 0.999 |
| 1:24086724:A:G | F573S | 0.999 |
| 1:24097986:A:C | Y228D | 0.999 |
| 1:24057446:T:A | N1411I | 0.998 |
| 1:24057452:A:T | V1409D | 0.998 |
| 1:24062047:A:G | L1278P | 0.998 |
| 1:24064135:A:C | Y1187D | 0.998 |
| 1:24074223:A:C | Y969D | 0.998 |
| 1:24075383:A:G | W932R | 0.998 |
| 1:24075383:A:T | W932R | 0.998 |
| 1:24076220:A:C | N880K | 0.998 |
| 1:24076220:A:T | N880K | 0.998 |
| 1:24080096:A:C | Y836D | 0.998 |
| 1:24080137:C:G | W822S | 0.998 |
| 1:24080143:A:G | L820P | 0.998 |
| 1:24082121:C:A | W720C | 0.998 |
| 1:24082121:C:G | W720C | 0.998 |
| 1:24082122:C:G | W720S | 0.998 |
| 1:24082667:A:T | V673D | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000022567 (1:24113097 G>A), RS1000031554 (1:24100729 A>G), RS1000120884 (1:24103222 C>T), RS1000215079 (1:24100909 A>G), RS1000272353 (1:24110523 C>T), RS1000306072 (1:24074343 G>A,T), RS1000329295 (1:24089849 T>C), RS1000425134 (1:24089856 A>G,T), RS1000485345 (1:24068745 G>A), RS1000498740 (1:24102191 C>T), RS1000514799 (1:24086568 G>C), RS1000606847 (1:24068545 T>C), RS1000612066 (1:24096399 C>T), RS1000612690 (1:24058175 G>A), RS1000775880 (1:24100543 C>G)
Disease associations
OMIM: gene MIM:616832 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001715_10 | Bipolar disorder with mood-incongruent psychosis | 4.000000e-06 |
| GCST006098_9 | Vigorous physical activity | 5.000000e-09 |
| GCST007576_232 | Chronotype | 3.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008002 | physical activity measurement |
| EFO:0008328 | chronotype measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| propionaldehyde | increases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| butyraldehyde | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| incobotulinumtoxinA | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Arsenic | decreases expression | 1 |
| Copper | decreases expression, affects cotreatment | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Niclosamide | increases expression | 1 |
| Rotenone | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.